D. E. Shaw & Co., Inc. T2 Biosystems, Inc. Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$0.28 - $1.23 $63,776 - $280,160	-227,773 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.96 - $2.94 $218,662 - $669,652	227,773 New	227,773 $266,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $358,792 - $825,944	-120,400 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.36 - $7.83 $234,076 - $341,943	-43,671 Reduced 26.62%	120,400 $897,000
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $979,503 - $1.57 Million	164,071 New	164,071 $1.27 Million
Q1 2018 May 15, 2018	SELL	$4.21 - $7.0 $82,899 - $137,837	-19,691 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.73 - $4.6 $73,447 - $90,578	19,691	19,691 $81,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.6M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.